On this page
Ordinary-course promises have actual limits
The August 2026 BioXcel/OnkosXcel–Teva agreement, section 4.2, contains interim-operation promises with bankruptcy, financing, legal and other exceptions. It illustrates why a headline “ordinary course” description cannot replace the actual permitted actions and consent provisions.
Record changes by their operating effect
Original fictional exercise: at signing, a workshop has three technicians, one critical supplier and a quoted customer project. Before the intended closing, one technician resigns, the supplier changes its terms and the quote becomes an accepted order. None of these facts automatically establishes a breach.
| Changed fact | Evidence and effect | Decision to obtain |
|---|---|---|
| Technician resignation | Actual departure, affected jobs and supported cover | Revisit day-one capacity and applicable employment tasks |
| Supplier terms | Current offer, price/payment and inputs affected | Reconcile delivery cost and funding assumptions |
| Accepted customer order | Operative terms, resources and delivery dates | Establish transaction treatment and ability to perform |
| New commitment or asset change | Date, amount, authority and operative contract provision | Determine any required notice, consent or other action |
Update the decision without rewriting history
Keep the signing baseline, new evidence, responsible checker and resulting decision together. Distinguish facts from allegations and a proposed action from an authorised completed one. Do not assume every adverse change triggers termination or every routine change needs buyer consent.
Give management the updated cash, capacity and closing-condition consequences. Any communication, waiver, amendment or decision to proceed needs the actual contractual authority and applicable legal assessment.
Use Management dependence to assign change monitoring and escalation. Keep the dated commercial records and any protected advice in the private deal file; the tool only identifies responsibilities.
Scope
- Selected historical interim-covenant example and original fictional changes only. No breach, material-adverse-effect, consent, pre-close-control or termination conclusion.
- The named Chapter 11 and financing exceptions are transaction-specific; no bankruptcy outcome or current deal completion is established.
Next step
Use Management dependence for change monitoring, checking and escalation; retain the dated signing-baseline/change/decision record separately.
Terms used here
- Interim period
- The interval defined by the agreement between signing and completion or another specified endpoint.
- Covenant
- A contractual promise to do or avoid specified things, subject to its actual scope and exceptions.
Sources & review notes
BioXcel Therapeutics; SEC-filed Exhibit 2.1
Passage, dates and research notes
company-filed-agreement · Preamble and section 4.2.1 opening exceptions and clauses(a)–(n), including relationships, personnel, contracts, assets and payment cycles; actual defined/interim scope
Historical named deal only; clauses and original fictional owner worksheet do not establish actual completion, enforcement, payment or ordinary-market terms. Selected historical interim-covenant example and original fictional changes only. No breach, material-adverse-effect, consent, pre-close-control or termination conclusion.
Bookmark this guide or mark it as read.
Progress privacy
Saving is off by default. Without it, progress lasts only on this page. If you turn it on, this browser profile stores public content IDs and the progress you record. Anyone sharing the profile could see them. No plan inputs or contact details are included. Reset or export in learning settings.
This is a reading aid, not evidence of disclosure delivery, expertise or legal approval.